Shares of Maravai LifeSciences ( NASDAQ: MRVI ) plunged 39% Friday, the day after the company issued a Q3 earnings report and updated revenue forecast that fell short of Street expectations. After market close on Thursday, Maravai ( MRVI ) reported an adjusted Q3.